[Form 4] The Chemours Company Insider Trading Activity
Denise Dignam, President & CEO and director of The Chemours Company (CC), purchased common stock on 08/08/2025. The Form 4 shows a purchase of 4,068 shares at a price of $12.06 per share, bringing her total reported beneficial ownership to 191,546.1549 shares. The filing notes the reported total includes directly owned shares, restricted stock units and dividend equivalent units.
The disclosure is a standard Section 16 insider report of a non-derivative acquisition and was submitted via Form 4. No options, conversions or derivative transactions are reported on this filing.
Denise Dignam, President & CEO e membro del consiglio di amministrazione di The Chemours Company (CC), ha acquistato azioni ordinarie il 08/08/2025. La Form 4 indica l'acquisto di 4,068 azioni al prezzo di $12.06 per azione, portando la sua detenzione beneficiaria complessiva dichiarata a 191,546.1549 azioni. Il deposito segnala che il totale riportato comprende azioni di propriet脿 diretta, unit脿 azionarie vincolate (restricted stock units) e unit脿 equivalenti ai dividendi (dividend equivalent units).
Si tratta di una normale segnalazione ai sensi della Sezione 16 relativa a un'acquisizione non derivata, presentata tramite Form 4. In questo filing non sono riportate opzioni, conversioni o operazioni su strumenti derivati.
Denise Dignam, Presidenta y CEO y directora de The Chemours Company (CC), compr贸 acciones ordinarias el 08/08/2025. El Form 4 muestra la compra de 4,068 acciones a un precio de $12.06 por acci贸n, elevando su participaci贸n beneficiosa total reportada a 191,546.1549 acciones. La presentaci贸n indica que el total informado incluye acciones de propiedad directa, unidades restringidas de acciones y unidades equivalentes a dividendos.
La divulgaci贸n corresponde a un informe t铆pico conforme a la Secci贸n 16 sobre una adquisici贸n no derivada y fue presentado mediante el Form 4. En este reporte no se informan opciones, conversiones ni transacciones sobre instrumentos derivados.
The Chemours Company (CC)鞚� President & CEO 瓴� 鞚挫偓鞚� Denise Dignam鞚� 2025雲� 8鞗� 8鞚� 氤错喌欤茧ゼ 毵れ垬頄堨姷雼堧嫟. Form 4鞐愲姅 欤茧嫻 $12.06鞐� 4,068欤�毳� 毵れ垬頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨溂氅�, 鞚措鞃� 攴鸽厐鞚� 鞁犼碃霅� 齑� 鞁れ 氤挫湢霟夓潃 191,546.1549欤�臧� 霅橃棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 頃措嫻 頃╆硠鞐� 歆侅爲 氤挫湢 欤检嫕, 鞝滍暅攵� 欤检嫕 雼渼(Restricted Stock Units) 氚� 氚半嫻 霌标皜 雼渼(Dividend Equivalent Units)臧� 韽暔霅橃柎 鞛堧嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
鞚� 瓿店皽電� 靹轨厴 16鞐� 霐半ジ 牍勴寣靸� 旆摑鞐� 甏�頃� 響滌 雮措秬鞛� 氤搓碃靹滊 Form 4毳� 韱淀暣 鞝滌稖霅橃棃鞀惦媹雼�. 氤� 鞁犼碃靹滌棎電� 鞓奠厴, 鞝勴櫂 霕愲姅 韺岇儩靸來拡 瓯半灅電� 氤搓碃霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Denise Dignam, Pr茅sidente & CEO et administratrice de The Chemours Company (CC), a achet茅 des actions ordinaires le 08/08/2025. Le formulaire 4 indique un achat de 4鈥�068 actions au prix de 12,06 $ par action, portant son int茅r锚t b茅n茅ficiaire total d茅clar茅 脿 191鈥�546,1549 actions. Le d茅p么t pr茅cise que le total d茅clar茅 comprend des actions d茅tenues directement, des restricted stock units et des dividend equivalent units.
La divulgation constitue une d茅claration standard au titre de la Section 16 concernant une acquisition non d茅riv茅e et a 茅t茅 soumise via le formulaire 4. Aucune option, conversion ou transaction sur produit d茅riv茅 n'est signal茅e dans ce d茅p么t.
Denise Dignam, Pr盲sidentin & CEO und Direktorin der The Chemours Company (CC), erwarb Stammaktien am 08.08.2025. Das Form 4 weist einen Kauf von 4.068 Aktien zu einem Preis von $12,06 pro Aktie aus, wodurch ihr insgesamt gemeldeter wirtschaftlicher Besitz 191.546,1549 Aktien betr盲gt. Die Einreichung vermerkt, dass die gemeldete Summe direkt gehaltene Aktien, Restricted Stock Units und Dividend Equivalent Units umfasst.
Die Offenlegung ist eine 眉bliche Meldung nach Section 16 眉ber eine nicht-derivative Erwerbung und wurde mittels Form 4 eingereicht. In dieser Meldung sind keine Optionen, Umwandlungen oder derivative Transaktionen angegeben.
- Insider purchase by CEO 鈥� Denise Dignam acquired 4,068 shares of Chemours common stock.
- Purchase price disclosed 鈥� the shares were bought at $12.06 per share.
- Total beneficial ownership reported 鈥� holdings increased to 191,546.1549 shares, including direct shares, restricted stock units and dividend equivalent units.
- None.
Insights
TL;DR: CEO purchased 4,068 Chemours shares at $12.06, modestly increasing direct ownership to 191,546.1549 shares 鈥� a positive insider buy signal.
The transaction is a straightforward open-market purchase recorded on a Form 4. At $12.06 per share, the acquisition size is modest relative to institutional holdings but is meaningful as a direct purchase by the company鈥檚 CEO and a serving director. Insider purchases can be interpreted as a signal of management confidence in near-term company prospects. The filing also clarifies that the reported total ownership aggregates direct holdings, restricted stock units and dividend equivalent units, which affects the composition but not the headline share count.
TL;DR: Routine Form 4 disclosure of an insider purchase by an executive-director; procedurally compliant and informative for governance monitoring.
This Form 4 provides required transparency about a senior executive鈥檚 equity purchases. It lists the reporting person鈥檚 roles (Director and President & CEO) and quantifies post-transaction holdings. From a governance standpoint, the filing meets disclosure expectations and the explanatory footnote on included share types clarifies the basis of the beneficial ownership total. There is no additional governance event or change disclosed.
Denise Dignam, President & CEO e membro del consiglio di amministrazione di The Chemours Company (CC), ha acquistato azioni ordinarie il 08/08/2025. La Form 4 indica l'acquisto di 4,068 azioni al prezzo di $12.06 per azione, portando la sua detenzione beneficiaria complessiva dichiarata a 191,546.1549 azioni. Il deposito segnala che il totale riportato comprende azioni di propriet脿 diretta, unit脿 azionarie vincolate (restricted stock units) e unit脿 equivalenti ai dividendi (dividend equivalent units).
Si tratta di una normale segnalazione ai sensi della Sezione 16 relativa a un'acquisizione non derivata, presentata tramite Form 4. In questo filing non sono riportate opzioni, conversioni o operazioni su strumenti derivati.
Denise Dignam, Presidenta y CEO y directora de The Chemours Company (CC), compr贸 acciones ordinarias el 08/08/2025. El Form 4 muestra la compra de 4,068 acciones a un precio de $12.06 por acci贸n, elevando su participaci贸n beneficiosa total reportada a 191,546.1549 acciones. La presentaci贸n indica que el total informado incluye acciones de propiedad directa, unidades restringidas de acciones y unidades equivalentes a dividendos.
La divulgaci贸n corresponde a un informe t铆pico conforme a la Secci贸n 16 sobre una adquisici贸n no derivada y fue presentado mediante el Form 4. En este reporte no se informan opciones, conversiones ni transacciones sobre instrumentos derivados.
The Chemours Company (CC)鞚� President & CEO 瓴� 鞚挫偓鞚� Denise Dignam鞚� 2025雲� 8鞗� 8鞚� 氤错喌欤茧ゼ 毵れ垬頄堨姷雼堧嫟. Form 4鞐愲姅 欤茧嫻 $12.06鞐� 4,068欤�毳� 毵れ垬頃� 瓴冹溂搿� 旮办灛霅橃柎 鞛堨溂氅�, 鞚措鞃� 攴鸽厐鞚� 鞁犼碃霅� 齑� 鞁れ 氤挫湢霟夓潃 191,546.1549欤�臧� 霅橃棃鞀惦媹雼�. 鞁犼碃靹滌棎電� 頃措嫻 頃╆硠鞐� 歆侅爲 氤挫湢 欤检嫕, 鞝滍暅攵� 欤检嫕 雼渼(Restricted Stock Units) 氚� 氚半嫻 霌标皜 雼渼(Dividend Equivalent Units)臧� 韽暔霅橃柎 鞛堧嫟瓿� 氇呾嫓霅橃柎 鞛堨姷雼堧嫟.
鞚� 瓿店皽電� 靹轨厴 16鞐� 霐半ジ 牍勴寣靸� 旆摑鞐� 甏�頃� 響滌 雮措秬鞛� 氤搓碃靹滊 Form 4毳� 韱淀暣 鞝滌稖霅橃棃鞀惦媹雼�. 氤� 鞁犼碃靹滌棎電� 鞓奠厴, 鞝勴櫂 霕愲姅 韺岇儩靸來拡 瓯半灅電� 氤搓碃霅橃柎 鞛堨 鞎婌姷雼堧嫟.
Denise Dignam, Pr茅sidente & CEO et administratrice de The Chemours Company (CC), a achet茅 des actions ordinaires le 08/08/2025. Le formulaire 4 indique un achat de 4鈥�068 actions au prix de 12,06 $ par action, portant son int茅r锚t b茅n茅ficiaire total d茅clar茅 脿 191鈥�546,1549 actions. Le d茅p么t pr茅cise que le total d茅clar茅 comprend des actions d茅tenues directement, des restricted stock units et des dividend equivalent units.
La divulgation constitue une d茅claration standard au titre de la Section 16 concernant une acquisition non d茅riv茅e et a 茅t茅 soumise via le formulaire 4. Aucune option, conversion ou transaction sur produit d茅riv茅 n'est signal茅e dans ce d茅p么t.
Denise Dignam, Pr盲sidentin & CEO und Direktorin der The Chemours Company (CC), erwarb Stammaktien am 08.08.2025. Das Form 4 weist einen Kauf von 4.068 Aktien zu einem Preis von $12,06 pro Aktie aus, wodurch ihr insgesamt gemeldeter wirtschaftlicher Besitz 191.546,1549 Aktien betr盲gt. Die Einreichung vermerkt, dass die gemeldete Summe direkt gehaltene Aktien, Restricted Stock Units und Dividend Equivalent Units umfasst.
Die Offenlegung ist eine 眉bliche Meldung nach Section 16 眉ber eine nicht-derivative Erwerbung und wurde mittels Form 4 eingereicht. In dieser Meldung sind keine Optionen, Umwandlungen oder derivative Transaktionen angegeben.
